FC
RMD icon

Financial Consulate’s ResMed RMD Stock Holding History

Financial Consulate’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.47K Buy
11
+1
+10% +$249 ﹤0.01% 942
2025
Q4 		$2.41K Hold
10
– – ﹤0.01% 853
2025
Q3 		$2.74K Buy
+10
New +$2.73K ﹤0.01% 745

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Financial Consulate's RMD Position: Q1 2026 in Review

Financial Consulate increased its ResMed (RMD) stake by 10% in Q1 2026, buying an estimated $249 and bringing the position to 11 shares worth $2.47K. The position accounts for ﹤0.01% of the portfolio, ranked #942.

Financial Consulate first reported a position in RMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.74K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Financial Consulate held 11 shares of ResMed worth $2.47K as of Q1 2026.
  • Financial Consulate bought 1 ResMed share in Q1 2026, an estimated $249.
  • ResMed made up ﹤0.01% of Financial Consulate's portfolio in Q1 2026, its #942 holding.
  • Financial Consulate first reported a position in ResMed in Q3 2025 and has held it in 3 quarters since.
  • Financial Consulate's ResMed position peaked at $2.74K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Financial Consulate's 13F filing for Q1 2026, filed 21 Apr 2026.